Givaudan Valuation

GVDNY Stock  USD 88.49  0.62  0.71%   
At this time, the firm appears to be overvalued. Givaudan SA ADR retains a regular Real Value of $78.02 per share. The prevalent price of the firm is $88.49. Our model calculates the value of Givaudan SA ADR from evaluating the firm fundamentals such as Return On Equity of 0.21, return on asset of 0.0598, and Current Valuation of 35.12 B as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
88.49
Please note that Givaudan's price fluctuation is very steady at this time. Calculation of the real value of Givaudan SA ADR is based on 3 months time horizon. Increasing Givaudan's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Givaudan is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Givaudan Pink Sheet. However, Givaudan's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  88.49 Real  78.02 Hype  88.49 Naive  90.55
The intrinsic value of Givaudan's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Givaudan's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
78.02
Real Value
97.34
Upside
Estimating the potential upside or downside of Givaudan SA ADR helps investors to forecast how Givaudan pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Givaudan more accurately as focusing exclusively on Givaudan's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
85.2987.4289.56
Details
Hype
Prediction
LowEstimatedHigh
87.3388.4989.65
Details
Naive
Forecast
LowNext ValueHigh
89.3990.5591.72
Details

Givaudan Total Value Analysis

Givaudan SA ADR is currently estimated to have takeover price of 35.12 B with market capitalization of 28.91 B, debt of 4.65 B, and cash on hands of 323 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Givaudan fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
35.12 B
28.91 B
4.65 B
323 M

Givaudan Investor Information

The company last dividend was issued on the 28th of March 2022. Based on the analysis of Givaudan's profitability, liquidity, and operating efficiency, Givaudan SA ADR is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.

Givaudan Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Givaudan has an asset utilization ratio of 61.84 percent. This suggests that the Company is making $0.62 for each dollar of assets. An increasing asset utilization means that Givaudan SA ADR is more efficient with each dollar of assets it utilizes for everyday operations.

Givaudan Ownership Allocation

Givaudan SA ADR has a total of 461.34 Million outstanding shares. Roughly 99.99 (percent) of Givaudan outstanding shares are held by general public with 0.007 pct. by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Givaudan Profitability Analysis

The company reported the revenue of 7.12 B. Net Income was 856 M with profit before overhead, payroll, taxes, and interest of 2.76 B.

About Givaudan Valuation

Our relative valuation model uses a comparative analysis of Givaudan. We calculate exposure to Givaudan's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Givaudan's related companies.
Givaudan SA, together with its subsidiaries, manufactures, supplies, and sells fragrance, beauty, taste, and wellbeing products to the consumer goods industry. The company was founded in 1796 and is headquartered in Vernier, Switzerland. Givaudan is traded on OTC Exchange in the United States.

8 Steps to conduct Givaudan's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Givaudan's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Givaudan's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Givaudan's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Givaudan's revenue streams: Identify Givaudan's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Givaudan's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Givaudan's growth potential: Evaluate Givaudan's management, business model, and growth potential.
  • Determine Givaudan's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Givaudan's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Givaudan Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Common Stock Shares Outstanding462.7 M
Quarterly Earnings Growth Y O Y0.229
Forward Price Earnings27.4725
Retained Earnings6.6 B

Additional Tools for Givaudan Pink Sheet Analysis

When running Givaudan's price analysis, check to measure Givaudan's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Givaudan is operating at the current time. Most of Givaudan's value examination focuses on studying past and present price action to predict the probability of Givaudan's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Givaudan's price. Additionally, you may evaluate how the addition of Givaudan to your portfolios can decrease your overall portfolio volatility.